Drug intelligence / Profile preview

technetium (99mTc) rhenium sulfide colloid

Development stage
Unknown
Lead developer
Curium
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Subcutaneous, Intradermal, Interstitial
01

Overview

Technetium (99mTc) rhenium sulfide colloid is a radiopharmaceutical diagnostic agent primarily utilized for lymphoscintigraphy and the identification of sentinel lymph nodes (SLN) in patients with solid tumors, most notably breast cancer and melanoma. The agent consists of a colloidal suspension of rhenium sulfide particles, typically ranging from 50 to 200 nm in diameter, labeled with the gamma-emitting radioisotope technetium-99m. Following interstitial injection (such as subcutaneous, intradermal, or peritumoral administration), the colloidal particles are transported via the lymphatic system to regional lymph nodes. Within these nodes, the particles are sequestered through phagocytosis by resident macrophages or by mechanical filtration within the lymph node sinusoids. This localization allows for the preoperative visualization of lymphatic drainage patterns using a gamma camera and the intraoperative detection of sentinel nodes using a hand-held gamma probe, facilitating targeted surgical biopsy and accurate cancer staging.

Brand names
Nanocis
Other names
technetium-99m colloidal rhenium sulphidetechnetium99m colloidal rhenium sulphidetechnetium 99m colloidal rhenium sulphide99mTc-rhenium sulfide colloidtechnetium Tc 99m rhenium sulfide99mTc-ReS

Beyond the preview

Go deeper on technetium (99mTc) rhenium sulfide colloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium (99mTc) rhenium sulfide colloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call